# Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/low-dose-spironolactone-combats-dyslipidemia-and-hepatic-inflammation-by/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kehinde S. Olaniyi,Stephanie E. Areloegbe,Emmanuel Damilare Areola,Isaiah Woru Sabinari,Adedamola Adediran Fafure,Richard Dele Agbana,Chukwubueze L. Atuma,Mohd Zahoor ul haq Shah,Isaac O. Ajadi,Lawrence A. Olatunji |
| Citations | 10 |
| DOI | 10.1016/j.taap.2023.116604 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4380680240 |
| PMID | 37328115 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Richard Dele Agbana](https://scholariq.org/researchers/richard-dele-agbana/)

## Paper journal

- [Toxicology and Applied Pharmacology](https://scholariq.org/journals/toxicology-and-applied-pharmacology/)

## Paper primary topic

- [Ovarian function and disorders](https://scholariq.org/topics/ovarian-function-and-disorders/)

## Paper topics

- [Ovarian function and disorders](https://scholariq.org/topics/ovarian-function-and-disorders/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Antioxidant Activity and Oxidative Stress](https://scholariq.org/topics/antioxidant-activity-and-oxidative-stress/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.